Enfortumab Vedotin Induced Hyperglycemia and Diabetic Ketoacidosis

被引:0
|
作者
Patel, J. [1 ]
机构
[1] Rush Univ, Med Ctr, Pulm & Crit Care Med, Chicago, IL 60612 USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A5298
引用
收藏
页数:1
相关论文
共 50 条
  • [31] From Hyperglycemia to Broken Heart Syndrome: A Case of Diabetic Ketoacidosis-Induced Takotsubo Cardiomyopathy
    Escano, Lorena
    Desai, Prarthana
    Chaudhry, Samir
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
  • [32] Hyponatremia in Pediatric Diabetic Ketoacidosis: Reevaluating the Correction Factor for Hyperglycemia
    Oh, Gia
    Anderson, Steve
    Tancredi, Daniel
    Kuppermann, Nathan
    Glaser, Nicole
    ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2009, 163 (08): : 771 - 772
  • [33] Enfortumab vedotin shows promise in solid tumours
    Burki, Talha Khan
    LANCET ONCOLOGY, 2020, 21 (03): : E133 - E133
  • [34] Pembrolizumab plus enfortumab vedotin in urothelial cancer
    Santoni, Matteo
    Takeshita, Hideki
    Massari, Francesco
    Bamias, Aristotelis
    Cerbone, Linda
    Fiala, Ondrej
    Mollica, Veronica
    Buti, Sebastiano
    Santoni, Angela
    Bellmunt, Joaquim
    NATURE REVIEWS UROLOGY, 2024, 21 (07) : 387 - 388
  • [35] Diabetic ketoacidosis and hyperosmolar hyperglycemia. 24 consecutive cases
    Rosival, V
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2003, 128 (12) : 634 - 634
  • [36] SGLT-2 inhibitors masking hyperglycemia in diabetic ketoacidosis
    Patel, D.
    Hamaad, M.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2024, 367 : S116 - S117
  • [37] HYPERGLYCEMIA WITH METABOLIC DERANGEMENTS: ALTERNATIVE ETIOLOGIES BEYOND DIABETIC KETOACIDOSIS
    Kening, Matthew
    Schumann, Jessica
    Gmora, Frederick
    Hanson, Katelyn A.
    Olarewaju, Olubunmi
    CHEST, 2022, 162 (04) : 684A - 684A
  • [38] INFUSION OF INSULIN IN LOW IN TREATING DIABETIC KETOACIDOSIS AND SEVERE HYPERGLYCEMIA
    MARADONAHIDALGO, JA
    CASTELLANOGARCIA, H
    GALANPEREZ, G
    MARTINEZESPEJO, A
    RODRIGOMORENO, M
    MEDICINA CLINICA, 1977, 68 (01): : 7 - 9
  • [39] Enfortumab vedotin 202: Phase 2 study of enfortumab vedotin for previously treated advanced solid tumors, including breast cancer
    Ono, Makiko
    Bruce, Justine Yang
    Feinstein, Trevor
    Muro, Kei
    Derleth, Christina
    Gorla, Seema
    Wu, Chunzhang
    Novik, Yelena
    CANCER RESEARCH, 2022, 82 (04)
  • [40] Canagliflozin induced diabetic ketoacidosis
    Dieguez-Felechosa, Marta
    Suarez-Gutierrez, Lorena
    ENDOCRINOLOGIA Y NUTRICION, 2016, 63 (08): : 430 - 431